The Association between the Bisphenols Residues in Amniotic Fluid and Fetal Abnormalities in Polish Pregnant Women-Its Potential Clinical Application.
Tomasz TuzimskiSzymon SzubartowskiAleksandra StupakAleksandra StupakMałgorzata Szultka-MłyńskaAnna KwaśniewskaBoguslaw BuszewskiPublished in: International journal of molecular sciences (2023)
The present study aimed to investigate the relationship between the concentrations of bisphenols residues in the amniotic fluid (AF) samples collected during amniocentesis and fetal chromosomal abnormalities in pregnant women. A total of 33 pregnant Polish women aged between 24 and 44 years, and screened to detect high risk for chromosomal defects in the first trimester, were included in this study. Samples were collected from these patients during routine diagnostic and treatment procedures at mid-gestation. The concentrations of various bisphenols residues in the samples were determined by liquid chromatography coupled with triple quadrupole tandem mass spectrometry (LC-ESI-QqQ-MS/MS). Residues of eight analytes (BPS, BPF, BPA, BPAF, BADGE, BADGE•2H 2 O, BADGE•H 2 O•HCl and BADGE•2HCl) were detected in amniotic fluid samples in the range 0.69 ng/mL to 3.38 ng/mL. Fetuses with chromosomal abnormalities showed a slightly higher frequency of occurrence of selected bisphenols residues in the AF samples collected between 15-26 weeks of pregnancies. Finally, the proposed method was applied in the simultaneous determination of several endocrine-disrupting chemicals from bisphenol group in 33 human AF samples. BADGE•H2O•HCl has been identified in the AF samples taken from women older than average in the examined group. The number of detected compounds has been significant for the following analytes: BPS, BPAF, BADGE•H 2 O•HCl and BADGE. The proposed method may be an attractive alternative for application in large-scale human biomonitoring studies.
Keyphrases
- tandem mass spectrometry
- simultaneous determination
- liquid chromatography
- ultra high performance liquid chromatography
- pregnant women
- high performance liquid chromatography
- mass spectrometry
- liquid chromatography tandem mass spectrometry
- ms ms
- atrial fibrillation
- solid phase extraction
- gas chromatography
- high resolution mass spectrometry
- endothelial cells
- gestational age
- copy number
- metabolic syndrome
- pregnancy outcomes
- high resolution
- gene expression
- insulin resistance
- newly diagnosed
- risk assessment
- pluripotent stem cells
- bone marrow
- replacement therapy
- community dwelling
- prognostic factors
- combination therapy
- patient reported outcomes
- case control
- middle aged